Zhengye Biotechnology Holding (ZYBT) Change in Taxes (2024 - 2025)

Zhengye Biotechnology Holding (ZYBT) reported Change in Taxes of $304000.0 for Q2 2025, up 5.7% quarter-over-quarter from $287619.7 in Q4 2024.

Zhengye Biotechnology Holding (ZYBT) Change in Taxes (2024 - 2025) Analysis & Trends

Zhengye Biotechnology Holding (ZYBT) has 2 years of Change in Taxes data on file, last reported at $304000.0 in Q2 2025.

Change in Taxes for Q2 2025 came in at $304000.0, changed N/A year-over-year; the trailing twelve-month figure through Jun 2025 was $304000.0 (changed N/A YoY), and the FY2025 annual result was $40000.0, up 229.03% from the prior year.
Change in Taxes advanced to $304000.0 in Q2 2025 per ZYBT's latest filing, from $287619.7 in the prior quarter.
Over five years, Change in Taxes peaked at $304000.0 in Q2 2025 and troughed at $287619.7 in Q4 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Change in Taxes (Qtr)
1	Teva Pharmaceutical Industries	39.72 Bn	35.98 Bn	1.97 Bn	-
2	Zoetis	34.61 Bn	32.67 Bn	1.62 Bn	73.00 Mn
3	United Therapeutics	24.07 Bn	21.91 Bn	648.10 Mn	-
4	Aurora Cannabis	16.98 Bn	16.91 Bn	33.43 Mn	-
5	Neurocrine Biosciences	16.64 Bn	15.32 Bn	800.70 Mn	119.80 Mn
6	Elanco Animal Health	12.19 Bn	11.76 Bn	785.00 Mn	-
7	Alkermes	7.37 Bn	6.86 Bn	-116.06 Mn	-
8	Hims & Hers Health	6.62 Bn	5.87 Bn	396.79 Mn	-
9	Lantheus Holdings	6.47 Bn	5.97 Bn	230.92 Mn	-
10	Zhengye Biotechnology Holding	5.49 Mn	6.20 Mn	-	-

Download Data